lower-vitamin-d-linked-to-central-lymph-node-metastasis-in-thyroid-cancer
Lower Vitamin D Linked to Central Lymph Node Metastasis in Thyroid Cancer

Lower Vitamin D Linked to Central Lymph Node Metastasis in Thyroid Cancer

A newly constructed transcriptomic signature based on vitamin D pathway genes demonstrates significant prognostic and classification value in thyroid cancer, while reduced circulating levels of 25-hydroxyvitamin D correlate with an increased risk of central lymph node metastasis in patients with papillary thyroid carcinoma. These dual findings, reported by Yue Yu, Yue Fan, and Yaohua Wu in BMC Endocrine Disorders, provide new molecular and clinical perspectives on the relationship between vitamin D status and the behavior of thyroid malignancies.

The investigators framed their investigation around the widespread global prevalence of vitamin D deficiency, emphasizing the clinical importance of determining how vitamin D pathway genes affect both the initial occurrence and subsequent progression of thyroid cancer. By elucidating these genetic mechanisms, the research team aimed to generate actionable insights to optimize existing clinical diagnostic pathways and treatment workflows for thyroid cancer, ultimately seeking to improve overall patient prognosis.

To evaluate these mechanisms thoroughly, the research team designed a study consisting of two independent analyses of vitamin D in thyroid cancer. The first component relied on computational bioinformatics to screen candidate genes within the vitamin D pathway that showed prognostic relevance in thyroid cancer, enabling the construction of a pathway score-associated signature. The second component examined real-world clinical and pathological records, specifically analyzing data collected from 343 patients diagnosed with papillary thyroid carcinoma.

The bioinformatics workflow established a specific five-gene signature comprising C1orf115, ZCCHC16, BMP8A, NGFR, and CITED1, which was evaluated as a candidate molecular marker for prognostic assessment in thyroid cancer. When tested across multiple independent patient cohorts, this feature gene set demonstrated robust classification performance for thyroid cancer, including papillary thyroid carcinoma, achieving an area under the receiver operating characteristic curve exceeding 0.8 in each evaluation.

Beyond overall classification performance, the authors identified marked genomic divergence when stratifying thyroid cancer profiles based on the pathway score.

Stratification according to the pathway score-associated signature also revealed distinct immunological and therapeutic profiles across the patient cohorts. Specifically, tumors in the low-risk group exhibited higher immune scores and lower tumor purity than those in the high-risk group. Additionally, the researchers identified significant differences in treatment sensitivity between the high- and low-score groups across multiple targeted therapies and chemotherapy drugs, suggesting clinical relevance for therapeutic stratification.

The clinical arm of the study, evaluating 343 patients with papillary thyroid carcinoma, revealed an inverse association between circulating vitamin D and disease spread. A reduction in serum 25-hydroxyvitamin D concentrations was significantly associated with an increased likelihood of central lymph node metastasis. Based on this observation, the researchers concluded that preoperative 25-hydroxyvitamin D measurements hold considerable potential for assessing metastatic risk in papillary thyroid carcinoma prior to surgical intervention, while the five-gene panel offers a viable molecular tool for clinical classification and prognostic evaluation.

Subject of Research: Vitamin D pathway transcriptomic signature and serum 25(OH)D association with thyroid cancer prognosis and metastasis

Article Title: Two independent analyses of vitamin D in thyroid cancer: a pathway score-associated transcriptomic signature and a retrospective study of serum 25(OH)D and central lymph node metastasis

Article References: Yu, Y., Fan, Y., & Wu, Y. (2026). Two independent analyses of vitamin D in thyroid cancer: a pathway score-associated transcriptomic signature and a retrospective study of serum 25(OH)D and central lymph node metastasis. BMC Endocrine Disorders. https://doi.org/10.1186/s12902-026-02740-x

Image Credits: AI Generated

DOI: 10.1186/s12902-026-02740-x

Keywords: vitamin D, thyroid cancer, papillary thyroid carcinoma, 25-hydroxyvitamin D, central lymph node metastasis, prognostic signature, transcriptomics, bioinformatics, C1orf115, ZCCHC16, BMP8A, NGFR, CITED1, immune scores, tumor purity, drug sensitivity, molecular markers, retrospective study